Login to Your Account

CAT, Abbott Settle Humira Dispute: Abbot Pays $255M

By Karen Pihl-Carey

Thursday, October 27, 2005
Ending a 2-year-old dispute, Cambridge Antibody Technology plc and Abbott Laboratories reached an agreement concerning Humira royalties payable to CAT under a 1995 deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription